特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

ウイルスベクターとプラスミドDNA の世界市場:Covid 19パンデミックの影響と成長

Viral Vectors & Plasmid DNA Global Market Report 2020-30: Covid 19 Implications and Growth

発行 The Business Research Company 商品コード 949228
出版日 ページ情報 英文 200 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=107.57円で換算しております。
ウイルスベクターとプラスミドDNA の世界市場:Covid 19パンデミックの影響と成長 Viral Vectors & Plasmid DNA Global Market Report 2020-30: Covid 19 Implications and Growth
出版日: 2020年07月14日 ページ情報: 英文 200 Pages
概要

当レポートは、世界のウイルスベクターとプラスミドDNA市場を調査したもので、国別、地域別の分析、競合情勢、合併と買収の動き、市場のトレンドや戦略、今後の展望や成長性の分析などを通じ、最大の市場と急成長している市場、全般的な景気動向や人口動態、他の隣接市場との関連、今後市場の方向性を決定づける要因を明らかにしています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特性

第3章 市場規模と成長性

  • 世界市場の実績:2015年~2019年
    • 市場の成長促進要因
    • 市場の成長阻害要因
  • 世界市場の予測:2019年~2023年、2025年、2030年
    • 市場の成長促進要因
    • 市場の成長阻害要因

第4章 市場区分

  • 製品別市場の実績と予測
    • プラスミドDNA
    • ウイルスベクター
  • 用途別市場の実績と予測
    • 遺伝子疾患とがんの治療
    • ウイルス感染症
    • 免疫療法
    • 製剤開発
    • その他

第5章 地域別、国別の分析

  • 地域別、国別の実績と予測

第6章 アジア太平洋

  • 市場の概要
  • 実績と予測

第7章 中国

  • 市場の概要
  • 実績と予測

第8章 インド

  • 市場の概要
  • 実績と予測

第9章 日本

  • 市場の概要
  • 実績と予測

第10章 オーストラリア

  • 市場の概要
  • 実績と予測

第11章 インドネシア

  • 市場の概要
  • 実績と予測

第12章 韓国

  • 市場の概要
  • 実績と予測

第13章 西欧

  • 市場の概要
  • 実績と予測

第14章 英国

  • 市場の概要
  • 実績と予測

第15章 ドイツ

  • 市場の概要
  • 実績と予測

第16章 フランス

  • 市場の概要
  • 実績と予測

第17章 東欧

  • 市場の概要
  • 実績と予測

第18章 ロシア

  • 市場の概要
  • 実績と予測

第19章 北米

  • 市場の概要
  • 実績と予測

第20章 米国

  • 市場の概要
  • 実績と予測

第21章 南米

  • 市場の概要
  • 実績と予測

第22章 ブラジル

  • 市場の概要
  • 実績と予測

第23章 中東

  • 市場の概要
  • 実績と予測

第24章 アフリカ

  • 市場の概要
  • 実績と予測

第25章 競合情勢と企業プロファイル

  • 競合情勢
  • 企業プロファイル
    • FUJIFILM Diosynth Biotechnologies
    • FinVector Vision Therapies
    • Lonza
    • Cobra Biologics and Pharmaceutical Services
    • Brammer Bio

第26章 主な合併と買収

第27章 市場の動向と戦略

第28章 今後の展望と将来性の分析

第29章 付録

目次

‘Viral Vectors & Plasmid DNA Global Market Report 2020-30: Covid 19 Implications and Growth ’ from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global viral vectors & plasmid dna market.

This report focuses on viral vectors & plasmid dna market which is experiencing strong growth. The report gives a guide to the viral vectors & plasmid dna market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the viral vectors & plasmid dna? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The ‘Viral Vectors & Plasmid DNA market global report’ from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider viral vectors & plasmid dna market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the Covid 19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The viral vectors & plasmid dna market section of the report gives context. It compares the viral vectors & plasmid dna market with other segments of the viral vectors & plasmid dna market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, viral vectors & plasmid dna indicators comparison.

Scope

Markets Covered:

  • 1) By Product: Plasmid DNA; Viral vectors
  • 2) By Applications: Gene And Cancer Therapies; Viral Infections; Immunotherapy; Formulation Development; Others
  • Companies Mentioned: FUJIFILM Diosynth Biotechnologies; FinVector Vision Therapies; Lonza; Cobra Biologics and Pharmaceutical Services; Brammer Bio
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Viral Vectors & Plasmid DNA Market Characteristics

3. Viral Vectors & Plasmid DNA Market Size And Growth

  • 3.1. Global Viral Vectors & Plasmid DNA Historic Market, 2015 - 2019, $ Billion
    • 3.1.1. Drivers Of The Market
    • 3.1.2. Restraints On The Market
  • 3.2. Global Viral Vectors & Plasmid DNA Forecast Market, 2019 - 2023F, 2025F, 2030F, $ Billion
    • 3.2.1. Drivers Of The Market
    • 3.2.2. Restraints On the Market

4. Viral Vectors & Plasmid DNA Market Segmentation

  • 4.1. Global Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
    • Plasmid DNA
    • Viral vectors
  • 4.2. Global Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
    • Gene And Cancer Therapies
    • Viral Infections
    • Immunotherapy
    • Formulation Development
    • Others

5. Viral Vectors & Plasmid DNA Market Regional And Country Analysis

  • 5.1. Global Viral Vectors & Plasmid DNA Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 5.2. Global Viral Vectors & Plasmid DNA Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

6. Asia-Pacific Viral Vectors & Plasmid DNA Market

  • 6.1. Asia-Pacific Viral Vectors & Plasmid DNA Market Overview
  • 6.2. Asia-Pacific Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 6.3. Asia-Pacific Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

7. China Viral Vectors & Plasmid DNA Market

  • 7.1. China Viral Vectors & Plasmid DNA Market Overview
  • 7.2. China Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 7.3. China Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

8. India Viral Vectors & Plasmid DNA Market

  • 8.1. India Viral Vectors & Plasmid DNA Market Overview
  • 8.2. India Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 8.3. India Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

9. Japan Viral Vectors & Plasmid DNA Market

  • 9.1. Japan Viral Vectors & Plasmid DNA Market Overview
  • 9.2. Japan Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 9.3. Japan Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

10. Australia Viral Vectors & Plasmid DNA Market

  • 10.1. Australia Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 10.2. Australia Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

11. Indonesia Viral Vectors & Plasmid DNA Market

  • 11.1. Indonesia Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 11.2. Indonesia Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

12. South Korea Viral Vectors & Plasmid DNA Market

  • 12.1. South Korea Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 12.2. South Korea Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

13. Western Europe Viral Vectors & Plasmid DNA Market

  • 13.1. Western Europe Viral Vectors & Plasmid DNA Market Overview
  • 13.2. Western Europe Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 13.3. Western Europe Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

14. UK Viral Vectors & Plasmid DNA Market

  • 14.1. UK Viral Vectors & Plasmid DNA Market Overview
  • 14.2. UK Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 14.3. UK Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

15. Germany Viral Vectors & Plasmid DNA Market

  • 15.1. Germany Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 15.2. Germany Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

16. France Viral Vectors & Plasmid DNA Market

  • 16.4. France Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 16.5. France Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

17. Eastern Europe Viral Vectors & Plasmid DNA Market

  • 17.1. Eastern Europe Viral Vectors & Plasmid DNA Market Overview
  • 17.2. Eastern Europe Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 17.3. Eastern Europe Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

18. Russia Viral Vectors & Plasmid DNA Market

  • 18.1. Russia Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 18.2. Russia Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

19. North America Viral Vectors & Plasmid DNA Market

  • 19.1. North America Viral Vectors & Plasmid DNA Market Overview
  • 19.2. North America Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 19.3. North America Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

20. USA Viral Vectors & Plasmid DNA Market

  • 20.1. USA Viral Vectors & Plasmid DNA Market Overview
  • 20.2. USA Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 20.3. USA Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

21. South America Viral Vectors & Plasmid DNA Market

  • 21.1. South America Viral Vectors & Plasmid DNA Market Overview
  • 21.2. South America Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 21.3. South America Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

22. Brazil Viral Vectors & Plasmid DNA Market

  • 22.1. Brazil Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 22.2. Brazil Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

23. Middle East Viral Vectors & Plasmid DNA Market

  • 23.1. Middle East Viral Vectors & Plasmid DNA Market Overview
  • 23.2. Middle East Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 23.3. Middle East Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

24. Africa Viral Vectors & Plasmid DNA Market

  • 24.1. Africa Viral Vectors & Plasmid DNA Market Overview
  • 24.2. Africa Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 24.3. Africa Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

25. Viral Vectors & Plasmid DNA Market Competitive Landscape And Company Profiles

  • 25.1. Viral Vectors & Plasmid DNA Market Competitive Landscape
  • 25.2. Viral Vectors & Plasmid DNA Market Company Profiles
    • 25.2.1. FUJIFILM Diosynth Biotechnologies
      • 25.2.1.1. Overview
      • 25.2.1.2. Products and Services
      • 25.2.1.3. Strategy
      • 25.2.1.4. Financial Performance
    • 25.2.2. FinVector Vision Therapies
      • 25.2.2.1. Overview
      • 25.2.2.2. Products and Services
      • 25.2.2.3. Strategy
      • 25.2.2.4. Financial Performance
    • 25.2.3. Lonza
      • 25.2.3.1. Overview
      • 25.2.3.2. Products and Services
      • 25.2.3.3. Strategy
      • 25.2.3.4. Financial Performance
    • 25.2.4. Cobra Biologics and Pharmaceutical Services
      • 25.2.4.1. Overview
      • 25.2.4.2. Products and Services
      • 25.2.4.3. Strategy
      • 25.2.4.4. Financial Performance
    • 25.2.5. Brammer Bio
      • 25.2.5.1. Overview
      • 25.2.5.2. Products and Services
      • 25.2.5.3. Strategy
      • 25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Viral Vectors & Plasmid DNA Market

27. Viral Vectors & Plasmid DNA Market Trends And Strategies

28. Viral Vectors & Plasmid DNA Market Future Outlook and Potential Analysis

29. Appendix

  • 29.1. Abbreviations
  • 29.2. Currencies
  • 29.3. Research Inquiries
  • 29.4. The Business Research Company
  • 29.5. Copyright And Disclaimer